QIAGEN N.V. Annual Report 2001

QIAGEN N.V. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (CONTINUED)
As of December 31,
LIABILITIES AND SHAREHOLDERS’ EQUITY
2001
2000
Current Liabilities:
Lines of credit
$ 6,038,000
$ 885,000
Short-term debt
281,000
6,382,000
Current portion of long-term debt
1,138,000
1,071,000
Current portion of capital lease obligations
1,085,000
1,043,000
Accounts payable
20,262,000
18,668,000
30
Accrued liabilities
Income taxes payable
20,235,000
8,434,000
15,878,000
1,712,000
Deferred income taxes
410,000
499,000
Total current liabilities
57,883,000
46,138,000
Long-Term Liabilities:
Long-term debt, net of current portion
70,720,000
11,552,000
Capital lease obligations, net of current portion
10,463,000
11,744,000
Deferred income taxes
–
549,000
Other
4,927,000
3,361,000
Total long-term liabilities
86,110,000
27,206,000
Minority Interest in Consolidated Subsidiaries
–
193,000
Commitments and Contingencies (Note 15)
Shareholders’ Equity:
Common shares, EUR 0.01 par value
Authorized—260,000,000 shares
Issued and outstanding—143,463,800 shares in
2001 and 142,548,487 shares in 2000
1,458,000
1,450,000
Additional paid-in capital
123,117,000
103,448,000
Retained earnings
97,278,000
62,859,000
Accumulated other comprehensive loss
(8,878,000)
(401,000)
Total shareholders’ equity
212,975,000
167,356,000
Total Liabilities and Shareholders’ Equity
$ 356,968,000
$ 240,893,000
The accompanying notes are an integral part of these consolidated balance sheets.